Preoperative CT scan helps to predict the occurrence of severe pancreatic fistula after pancreaticoduodenectomy

Annals of Surgery

Volumn 256, Issue 1, 2012, Pages 139-145

  Tranchart, Hadrien ^a   Gaujoux, Sébastien ^a,b   Rebours, Vinciane ^a,b   Vullierme, Marie Pierre ^a,b   Dokmak, Safi ^a,b   Levy, Philippe ^a,b   Couvelard, Anne ^a,b   Belghiti, Jacques ^a,b   Sauvanet, Alain ^a,b  

^a BEAUJON HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HISTOLOGY; HUMAN; LIVER; MAJOR CLINICAL STUDY; MALE; OBESITY; PANCREAS; PANCREAS FISTULA; PANCREATICODUODENECTOMY; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SPLEEN; SUBCUTANEOUS FAT;

ABDOMINAL FAT; ADENOCARCINOMA; AGED; CARCINOMA, PAPILLARY; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; LIVER; LOGISTIC MODELS; MALE; MIDDLE AGED; PANCREAS; PANCREATIC FISTULA; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; RISK FACTORS; SPLEEN; SUBCUTANEOUS FAT, ABDOMINAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84863304513     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318256c32c     Document Type: Article

References (51)

1. DeOliveira ML,Winter JM, Schafer M, et al.Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg. 2006;244:931-937.
2. Cameron JL, Riall TS, Coleman J, et al. One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006;244:10-15.
3. Schmidt CM, Choi J, Powell ES, et al. Pancreatic fistula following pancreaticoduodenectomy: clinical predictors and patient outcomes. HPB Surg. 2009;2009:404520.
4. de Castro SM, Busch OR, van Gulik TM, et al. Incidence and management of pancreatic leakage after pancreatoduodenectomy. Br J Surg. 2005;92:1117-1123.
5. Pratt WB, Callery MP, Vollmer CM, Jr. Risk prediction for development of pancreatic fistula using the ISGPF Classification Scheme. World J Surg. 2008;32:419-428.
6. Kazanjian KK, Hines OJ, Eibl G, et al. Management of pancreatic fistulas after pancreaticoduodenectomy: results in 437 consecutive patients. Arch Surg. 2005;140:849-854.
7. Peng SY, Wang JW, Lau WY, et al. Conventional versus binding pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial. Ann Surg. 2007;245:692-698.
8. Pessaux P, Sauvanet A, Mariette C, et al. External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospectivemulticenter randomized trial. Ann Surg. 2011;253:879-885.
9. Poon RT, Fan ST, Lo CM, et al. External drainage of pancreatic duct with a stent to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial. Ann Surg. 2007;246:425-433.
10. Marcus SG, Cohen H, Ranson JH. Optimal management of the pancreatic remnant after pancreaticoduodenectomy. Ann Surg. 1995;221:635-645.
11. Yang YM, Tian XD, Zhuang Y, et al. Risk factors of pancreatic leakage after pancreaticoduodenectomy. World J Gastroenterol. 2005;11:2456-2461.
12. Ho V, Heslin MJ. Effect of hospital volume and experience on in-hospital mortality for pancreaticoduodenectomy. Ann Surg. 2003;237:509-514.
13. Molinari E, Bassi C, Salvia R, et al. Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. Ann Surg. 2007;246:281-287.
14. Lin JW, Cameron JL, Yeo CJ, et al. Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg. 2004;8:951-959.
15. Mathur A, Marine M, Lu D, et al. Nonalcoholic fatty pancreas disease. HPB (Oxford). 2007;9:312-318.
16. Gaujoux S, Cortes A, Couvelard A, et al. Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy. Surgery. 2010;148:15-23.
17. Rosso E, Casnedi S, Pessaux P, et al. The role of "fatty pancreas" and of BMI in the occurrence of pancreatic fistula after pancreaticoduodenectomy. J Gastrointest Surg. 2009;13:1845-1851.
18. Mathur A, Pitt HA, Marine M, et al. Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg. 2007;246:1058-1064.
19. Lee SE, Jang JY, Lim CS, et al. Measurement of pancreatic fat by magnetic resonance imaging: predicting the occurrence of pancreatic fistula after pancreatoduodenectomy. Ann Surg. 2010;251:932-936.
20. Lingvay I, EsserV, Legendre JL, et al.Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab. 2009;94:4070-4076.
21. Al-Haddad M, Khashab M, Zyromski N, et al. Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study. Pancreas. 2009;38:672-675.
22. House MG, Fong Y, Arnaoutakis DJ, et al. Preoperative Predictors for Complications after Pancreaticoduodenectomy: impact of BMI and Body Fat Distribution. J Gastrointest Surg. 2008;12:270-278.
23. Olsen TS. Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Pathol Microbiol Scand A. 1978;86A:367-373.
24. Weinsier RL, Hunter GR, Gower BA, et al. Body fat distribution in white and black women: different patterns of intraabdominal and subcutaneous abdominal adipose tissue utilization with weight loss. Am J Clin Nutr. 2001;74:631-636.
25. Goodpaster BH. Measuring body fat distribution and content in humans. Curr Opin Clin Nutr Metab Care. 2002;5:481-487.
26. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
27. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8-13.
28. Ammann RW, Heitz PU, Kloppel G. Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology. 1996;111:224-231.
29. Guiu B, Petit JM, Bonnetain F, et al. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer. Gut. 2010;59:341-347.
30. Iwasaki M, Takada Y, Hayashi M, et al. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation. 2004;78:1501-1505.
31. Goh BK, Tan YM, Chung YF, et al. Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution. Arch Surg. 2008;143:956-965.
32. Noun R, Riachy E, Ghorra C, et al. The impact of obesity on surgical outcome after pancreaticoduodenectomy. JOP. 2008;9:468-476.
33. Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat. 2007;20:933-942.
34. Hu HH, Kim HW, Nayak KS, et al. Comparison of fat-water MRI and singlevoxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity (Silver Spring). 2010;18:841-847.
35. Kovanlikaya A, Mittelman SD, Ward A, et al. Obesity and fat quantification in lean tissues using three-point Dixon MR imaging. Pediatr Radiol. 2005;35:601-607.
36. Schwenzer NF, Machann J, Martirosian P, et al. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Invest Radiol. 2008;43:330-337.
37. Kim Z, Kim MJ, Kim JH, et al. Prediction of post-operative pancreatic fistula in pancreaticoduodenectomy patients using pre-operative MRI: a pilot study. HPB (Oxford). 2009;11:215-221.
38. Zyromski NJ, Mathur A, Gowda GA, et al. Nuclear magnetic resonance spectroscopy-based metabolomics of the fatty pancreas: implicating fat in pancreatic pathology. Pancreatology. 2009;9:410-419.
39. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21:697-738.
40. Park BJ, Kim YJ, Kim DH, et al. Visceral adipose tissue area is an independent risk factor for hepatic steatosis. J Gastroenterol Hepatol. 2008;23:900-907.
41. Smits MM, van Geenen EJ. The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol. 2011;8:169-177.
42. vanGeenen EJ, SmitsMM,SchreuderTC, et al.Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas. 2010;39:1185-1190.
43. Lee JS, Kim SH, Jun DW, et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol. 2009;15:1869-1875.
44. Gaujoux S, Sauvanet A, Couvelard A, et al. Response to "Obesity potentiates the growth and dissemination of pancreatic cancer." Surgery. 2010;147:174.
45. Zyromski NJ, Mathur A, Pitt HA, et al. Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery. 2009;146:258-263.
46. Wade TE, Mathur A, Lu D, et al. Adiponectin receptor-1 expression is decreased in the pancreas of obese mice. J Surg Res. 2009;154:78-84.
47. Ogden CL, CarrollMD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
48. Ishii Y, Hasegawa H, Nishibori H, et al. Impact of visceral obesity on surgical outcome after laparoscopic surgery for rectal cancer. Br J Surg. 2005;92:1261-1262.
49. Cecchini S, Cavazzini E, Marchesi F, et al. Computed tomography volumetric fat parameters versus body mass index for predicting short-term outcomes of colon surgery. World J Surg. 2011;35:415-423.
50. Seki Y, Ohue M, Sekimoto M, et al. Evaluation of the technical difficulty performing laparoscopic resection of a rectosigmoid carcinoma: visceral fat reflects technical difficulty more accurately than body mass index. Surg Endosc. 2007;21:929-934.
51. Balentine CJ, Enriquez J, FisherW, et al. Intra-abdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg. 2010;14:1832-1837.